In summary, the upregulation of circulating SDCBP and PRKAR1A in AMI patients with HF progression might modulate cardiac remodeling via a complex molecular regulatory network and serve as a potential therapeutic target of post-AMI HF. The gene discussed is SDCBP; the disease is hydrops fetalis.